I propose to take Questions Nos. 47, 49 and 127 together.
The National Cancer Registry Board recorded a total of 1,061 new cases of prostate cancer in 1994 and 1,084 in 1995, the latest year for which complete information is available. It is difficult to estimate the true incidence (i.e. number of new cases) of prostate cancer because of the nature of the disease.
Many prostate cancers are not fatal and do not cause symptoms during the patient's lifetime. In these circumstances the cancer is only identified incidentally when the patient has surgery for benign prostatic disease. As the number of men having surgery for benign disease increases, so too will the detection of prostate cancer. This gives rise to an increase in the number of prostate cancers detected but does not necessarily mean that the true incidence of prostate cancer is increasing.
While there has been an upward trend in deaths from prostate cancer, this may be due to more comprehensive diagnosis and investigation, together with increased longevity among men in recent years.
The Health Research Board has funded research into prostate cancer, including therapeutic research, in recent years. Funding of £80,000 has been provided to the Health Research Board under the national cancer strategy for a separate programme of clinical research into all forms of cancer, with particular emphasis on multi-institutional and multi-discriplinary research. The Health Research Board is currently evaluating applications in this regard.